Etropal AD (BUL:ETR)

Market Cap	22.27M -21.9%
Revenue (ttm)	20.24M +28.5%
Net Income	324.00K +272.4%
EPS	0.06 +272.4%
Shares Out	5.00M
PE Ratio	69.39
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	70
Open	2.300
Previous Close	n/a
Day's Range	2.300 - 2.300
52-Week Range	1.936 - 2.340
Beta	0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 5, 2026

About Etropal AD

Etropal AD engages in the development, manufacture, and sale of disposable medical devices for dialysis in Bulgaria. The company offers capillary dialyzers; arterial-venous blood line sets; procedure kits; and arterial-venous fistula needles. Etropal AD was founded in 1976 and is headquartered in Etropole, Bulgaria. Etropal AD is a subsidiary of Synthetica AD.

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1976
• Employees: 99
• Stock Exchange: Bulgarian Stock Exchange
• Ticker Symbol: ETR

Financial Performance

In 2025, Etropal AD's revenue was 20.24 million, an increase of 28.55% compared to the previous year's 15.75 million. Earnings were 324,000, an increase of 272.41%.